Oxygen Conservation Devices Market Overcomes Pandemic Strom as Increasing Covid-19 Cases Highlights Importance of Medical Oxygen Conservation
An oxygen conservation device (OCD) is used
to control the flow of oxygen from the oxygen source to the patient. The device
releases oxygen only when the patient inhales. This in turn increases the
amount of time a patient can use the oxygen supply. There are two types of
oxygen conserving devices: the fixed-pulse type and the demand-pulse units.
These devices help providers by reducing the frequency of refills, cylinders,
and deliveries. They monitor the patient's breathing patterns and adjust the
oxygen dose depending on the patient's needs.
Oxygen conservation devices offers various
advantages. They are compact and lightweight and are ideal for home use. Some
OCDs are battery operated. A single set of batteries can offer power for up to
one year. These devices are extremely efficient and have the ability to
automatically modify oxygen output.
Emergence of Covid-19 has led to
significant growth in the oxygen
conservation devices market. Globally, as of 4:53pm CET, 18 March 2021,
there have been 120,915,219 confirmed cases of COVID-19, including 2,674,078
deaths, as reported to the World Health Organization. Such scenario has created
a desperate lack of medical oxygen for Covid-19 patients, which boosts demand
for OCD.
Oxygen conservation devices also find
application in the treatment and management of Chronic Obstructive Pulmonary
Disease (COPD). In Latin America, the oxygen conservation devices market is
driven by high cases of COPD. According to the study ‘Chronic Obstructive
Pulmonary Disease in Latin America’, published in January 2019 in the journal
Annals of Global Health, the prevalence of COPD in Latin American cities ranged
between 6.2 and 19.6% in individuals aged 40 years and above.
Oxygen conservation devices are used in emergency
surgeries where constant supply of oxygen is required. Admissions for emergency
surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals
and by 5.1% in private hospitals in Australia, according to Australian
Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated
in August 2019. Thus, Australia may witness significant growth in oxygen
conservation devices market.
According
to The Global Asthma Report 2018, the prevalence of asthma symptoms was 23% and
the prevalence of a medical diagnosis of asthma 12% in Brazil. Thus, Latin
America is also expected to witness significant growth in the oxygen
conservation devices market.

Comments
Post a Comment